TXNIP and gastric carcinoma: TXNIP overexpression in the human gastric carcinoma cell lines AGS, SNU-16, and SNU-620, the promyelocytic leukemia cell line HL-60, and HTLV-I-positive T cells led to growth reduction in vitro[8,22,48].